京城生物科技

Beijing Jingcheng Biological Technology is a Chinese biotechnology company specializing in regenerative medicine and advanced cell therapies. As a subsidiary of the state-owned Beijing Jingcheng Machinery Electric Holding, the company leverages significant industrial resources to develop automated cell processing systems and large-scale biobanking infrastructure. Its research and development efforts are primarily focused on Mesenchymal Stem Cell (MSC) and Natural Killer (NK) cell technologies for treating degenerative diseases and oncology indications. In addition to its therapeutic pipeline, the company provides comprehensive technical services for biological sample storage and cellular engineering. Beijing Jingcheng aims to bridge the gap between laboratory research and clinical application within the evolving Chinese healthcare landscape.